女性用避妊薬の世界市場 2023-2027

当レポートでは女性用避妊薬の市場規模は、2023年から2027年の間に51億4,222万米ドル、予測期間中のCAGRは5.32%で成長すると予測しています。当レポートでは、女性用避妊薬市場の全体的な分析、市場規模・予測、動向、成長促進要因・課題、約25のベンダーを網羅したベンダー分析を行っています。

現在の世界の市場動向と促進要因、市場全体の環境に関する最新の分析を提供しています。

市場は、革新的なマーケティング戦略の採用の増加、消費者の視点の進化、さまざまな避妊方法の利用可能性によって牽引されています。

本調査では、今後数年間の女性用避妊薬市場の成長を牽引する主要な理由の1つとして、女性用コンドームの普及率の上昇を挙げています。また、IUSの技術的進歩やeコマースプラットフォームの高成長は、市場の大きな需要につながると考えられます。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2022
• 市場の見通し：2022-2027年の予測

第4章 市場規模実績

• 世界の女性用避妊薬市場：2017-2021
• 流通チャネルセグメント分析2017-2021
• 製品セグメント分析2017-2021
• 地域セグメント分析2017-2021
• 国セグメント分析2017-2021

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 流通チャネル別市場セグメンテーション

• 市場内訳
• 流通チャネル別比較
• オフライン - 市場規模と予測 2022-2027
• オンライン - 市場規模と予測 2022-2027
• 流通チャネル別の市場機会

第7章 製品別の市場セグメンテーション

• 市場内訳
• 製品別比較
• 女性用避妊具 - 市場規模と予測 2022-2027
• 女性用避妊薬 - 市場規模と予測 2022-2027
• 製品別の市場機会

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米 - 市場規模と予測 2022-2027
• 欧州 - 市場規模と予測 2022-2027
• APAC - 市場規模と予測 2022-2027
• 南米 - 市場規模と予測 2022-2027
• 中東およびアフリカ - 市場規模と予測 2022-2027
• 米国 - 市場規模と予測 2022-2027
• 中国 - 市場規模と予測 2022-2027
• フランス - 市場規模と予測 2022-2027
• カナダ - 市場規模と予測 2022-2027
• 日本 - 市場規模と予測 2022-2027
• 地域情勢別の市場機会

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• AbbVie Inc.
• Afaxys Pharma LLC
• Agile Therapeutics Inc.
• Ansell Ltd.
• Bayer AG
• CooperSurgical Inc.
• Cupid Ltd.
• Johnson and Johnson
• Mayer Laboratories Inc.
• Merck and Co. Inc.
• Mylan NV
• Pfizer Inc.
• Reckitt Benckiser Group PLC
• Teva Pharmaceutical Industries Ltd.
• Veru Inc.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibits6: Executive Summary - Chart on Market Segmentation by Product
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on Global female contraceptive market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibits31: Data Table on Distribution Channel - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Distribution Channel
• Exhibits33: Data Table on Comparison by Distribution Channel
• Exhibits34: Chart on Offline - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Offline - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Offline - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Online - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on Online - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on Online - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Online - Year-over-year growth 2022-2027 (%)
• Exhibits42: Market opportunity by Distribution Channel ($ million)
• Exhibits43: Chart on Product - Market share 2022-2027 (%)
• Exhibits44: Data Table on Product - Market share 2022-2027 (%)
• Exhibits45: Chart on Comparison by Product
• Exhibits46: Data Table on Comparison by Product
• Exhibits47: Chart on Female contraceptive devices - Market size and forecast 2022-2027 ($ million)
• Exhibits48: Data Table on Female contraceptive devices - Market size and forecast 2022-2027 ($ million)
• Exhibits49: Chart on Female contraceptive devices - Year-over-year growth 2022-2027 (%)
• Exhibits50: Data Table on Female contraceptive devices - Year-over-year growth 2022-2027 (%)
• Exhibits51: Chart on Female contraceptive drugs - Market size and forecast 2022-2027 ($ million)
• Exhibits52: Data Table on Female contraceptive drugs - Market size and forecast 2022-2027 ($ million)
• Exhibits53: Chart on Female contraceptive drugs - Year-over-year growth 2022-2027 (%)
• Exhibits54: Data Table on Female contraceptive drugs - Year-over-year growth 2022-2027 (%)
• Exhibits55: Market opportunity by Product ($ million)
• Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits57: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits59: Chart on Geographic comparison
• Exhibits60: Data Table on Geographic comparison
• Exhibits61: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits63: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits64: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits67: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits69: Chart on APAC - Market size and forecast 2022-2027 ($ million)
• Exhibits70: Data Table on APAC - Market size and forecast 2022-2027 ($ million)
• Exhibits71: Chart on APAC - Year-over-year growth 2022-2027 (%)
• Exhibits72: Data Table on APAC - Year-over-year growth 2022-2027 (%)
• Exhibits73: Chart on South America - Market size and forecast 2022-2027 ($ million)
• Exhibits74: Data Table on South America - Market size and forecast 2022-2027 ($ million)
• Exhibits75: Chart on South America - Year-over-year growth 2022-2027 (%)
• Exhibits76: Data Table on South America - Year-over-year growth 2022-2027 (%)
• Exhibits77: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
• Exhibits78: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
• Exhibits79: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
• Exhibits80: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)
• Exhibits81: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits82: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits83: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits84: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits85: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibits86: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibits87: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits88: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits89: Chart on France - Market size and forecast 2022-2027 ($ million)
• Exhibits90: Data Table on France - Market size and forecast 2022-2027 ($ million)
• Exhibits91: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibits92: Data Table on France - Year-over-year growth 2022-2027 (%)
• Exhibits93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits95: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibits98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibits99: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibits100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
• Exhibits101: Market opportunity By Geographical Landscape ($ million)
• Exhibits102: Impact of drivers and challenges in 2022 and 2027
• Exhibits103: Overview on Criticality of inputs and Factors of differentiation
• Exhibits104: Overview on factors of disruption
• Exhibits105: Impact of key risks on business
• Exhibits106: Vendors covered
• Exhibits107: Matrix on vendor position and classification
• Exhibits108: AbbVie Inc. - Overview
• Exhibits109: AbbVie Inc. - Product / Service
• Exhibits110: AbbVie Inc. - Key offerings
• Exhibits111: Afaxys Pharma LLC - Overview
• Exhibits112: Afaxys Pharma LLC - Product / Service
• Exhibits113: Afaxys Pharma LLC - Key offerings
• Exhibits114: Agile Therapeutics Inc. - Overview
• Exhibits115: Agile Therapeutics Inc. - Product / Service
• Exhibits116: Agile Therapeutics Inc. - Key offerings
• Exhibits117: Ansell Ltd. - Overview
• Exhibits118: Ansell Ltd. - Business segments
• Exhibits119: Ansell Ltd. - Key news
• Exhibits120: Ansell Ltd. - Key offerings
• Exhibits121: Ansell Ltd. - Segment focus
• Exhibits122: Bayer AG - Overview
• Exhibits123: Bayer AG - Business segments
• Exhibits124: Bayer AG - Key offerings
• Exhibits125: Bayer AG - Segment focus
• Exhibits126: CooperSurgical Inc. - Overview
• Exhibits127: CooperSurgical Inc. - Product / Service
• Exhibits128: CooperSurgical Inc. - Key offerings
• Exhibits129: Cupid Ltd. - Overview
• Exhibits130: Cupid Ltd. - Product / Service
• Exhibits131: Cupid Ltd. - Key offerings
• Exhibits132: Johnson and Johnson - Overview
• Exhibits133: Johnson and Johnson - Business segments
• Exhibits134: Johnson and Johnson - Key news
• Exhibits135: Johnson and Johnson - Key offerings
• Exhibits136: Johnson and Johnson - Segment focus
• Exhibits137: Mayer Laboratories Inc. - Overview
• Exhibits138: Mayer Laboratories Inc. - Product / Service
• Exhibits139: Mayer Laboratories Inc. - Key offerings
• Exhibits140: Merck and Co. Inc. - Overview
• Exhibits141: Merck and Co. Inc. - Business segments
• Exhibits142: Merck and Co. Inc. - Key news
• Exhibits143: Merck and Co. Inc. - Key offerings
• Exhibits144: Merck and Co. Inc. - Segment focus
• Exhibits145: Mylan NV - Overview
• Exhibits146: Mylan NV - Business segments
• Exhibits147: Mylan NV - Key offerings
• Exhibits148: Mylan NV - Segment focus
• Exhibits149: Pfizer Inc. - Overview
• Exhibits150: Pfizer Inc. - Product / Service
• Exhibits151: Pfizer Inc. - Key news
• Exhibits152: Pfizer Inc. - Key offerings
• Exhibits153: Reckitt Benckiser Group PLC - Overview
• Exhibits154: Reckitt Benckiser Group PLC - Business segments
• Exhibits155: Reckitt Benckiser Group PLC - Key offerings
• Exhibits156: Reckitt Benckiser Group PLC - Segment focus
• Exhibits157: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits158: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits159: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits160: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits161: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits162: Veru Inc. - Overview
• Exhibits163: Veru Inc. - Business segments
• Exhibits164: Veru Inc. - Key offerings
• Exhibits165: Veru Inc. - Segment focus
• Exhibits166: Inclusions checklist
• Exhibits167: Exclusions checklist
• Exhibits168: Currency conversion rates for US$
• Exhibits169: Research methodology
• Exhibits170: Validation techniques employed for market sizing
• Exhibits171: Information sources
• Exhibits172: List of abbreviations

Technavio has been monitoring the female contraceptive market and it is poised to grow by $5142.22 mn during 2023-2027, accelerating at a CAGR of 5.32% during the forecast period. Our report on the female contraceptive market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing adoption of innovative marketing strategies, evolving consumer perspectives, and the availability of different methods of contraception.

Technavio's female contraceptive market is segmented as below:

By Distribution Channel

• Offline
• Online

By Product

• Female contraceptive devices
• Female contraceptive drugs

By Geographical Landscape

• North America
• Europe
• APAC
• South America
• Middle East and Africa

This study identifies the increasing popularity of female condoms as one of the prime reasons driving the female contraceptive market growth during the next few years. Also, technological advances in IUSs and the high growth of e-commerce platforms will lead to sizable demand in the market.

• Female contraceptive market sizing
• Female contraceptive market forecast
• Female contraceptive market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading female contraceptive market vendors that include AbbVie Inc., Afaxys Pharma LLC, Agile Therapeutics Inc., Amgen Inc., Ansell Ltd., Bayer AG, CooperSurgical Inc., Cupid Ltd., Exeltis USA Inc., Johnson and Johnson, Mayer Laboratories Inc., Medisafe Distribution Inc., Merck and Co. Inc., Mylan NV, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group PLC, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Veru Inc. Also, the female contraceptive market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global female contraceptive market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on Global female contraceptive market 2017 - 2021 ($ million)
• 4.2 Distribution Channel Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
• 4.3 Product Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Distribution Channel

• 6.1 Market segments
• Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
• 6.2 Comparison by Distribution Channel
• Exhibit 32: Chart on Comparison by Distribution Channel
• Exhibit 33: Data Table on Comparison by Distribution Channel
• 6.3 Offline - Market size and forecast 2022-2027
• Exhibit 34: Chart on Offline - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Offline - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Offline - Year-over-year growth 2022-2027 (%)
• 6.4 Online - Market size and forecast 2022-2027
• Exhibit 38: Chart on Online - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Online - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Online - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Online - Year-over-year growth 2022-2027 (%)
• 6.5 Market opportunity by Distribution Channel
• Exhibit 42: Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by Product

• 7.1 Market segments
• Exhibit 43: Chart on Product - Market share 2022-2027 (%)
• Exhibit 44: Data Table on Product - Market share 2022-2027 (%)
• 7.2 Comparison by Product
• Exhibit 45: Chart on Comparison by Product
• Exhibit 46: Data Table on Comparison by Product
• 7.3 Female contraceptive devices - Market size and forecast 2022-2027
• Exhibit 47: Chart on Female contraceptive devices - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Data Table on Female contraceptive devices - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Chart on Female contraceptive devices - Year-over-year growth 2022-2027 (%)
• Exhibit 50: Data Table on Female contraceptive devices - Year-over-year growth 2022-2027 (%)
• 7.4 Female contraceptive drugs - Market size and forecast 2022-2027
• Exhibit 51: Chart on Female contraceptive drugs - Market size and forecast 2022-2027 ($ million)
• Exhibit 52: Data Table on Female contraceptive drugs - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Chart on Female contraceptive drugs - Year-over-year growth 2022-2027 (%)
• Exhibit 54: Data Table on Female contraceptive drugs - Year-over-year growth 2022-2027 (%)
• 7.5 Market opportunity by Product
• Exhibit 55: Market opportunity by Product ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 57: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 59: Chart on Geographic comparison
• Exhibit 60: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 61: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 63: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 64: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 67: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 APAC - Market size and forecast 2022-2027
• Exhibit 69: Chart on APAC - Market size and forecast 2022-2027 ($ million)
• Exhibit 70: Data Table on APAC - Market size and forecast 2022-2027 ($ million)
• Exhibit 71: Chart on APAC - Year-over-year growth 2022-2027 (%)
• Exhibit 72: Data Table on APAC - Year-over-year growth 2022-2027 (%)
• 9.6 South America - Market size and forecast 2022-2027
• Exhibit 73: Chart on South America - Market size and forecast 2022-2027 ($ million)
• Exhibit 74: Data Table on South America - Market size and forecast 2022-2027 ($ million)
• Exhibit 75: Chart on South America - Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on South America - Year-over-year growth 2022-2027 (%)
• 9.7 Middle East and Africa - Market size and forecast 2022-2027
• Exhibit 77: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
• Exhibit 79: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)
• 9.8 US - Market size and forecast 2022-2027
• Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.9 China - Market size and forecast 2022-2027
• Exhibit 85: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.10 France - Market size and forecast 2022-2027
• Exhibit 89: Chart on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on France - Year-over-year growth 2022-2027 (%)
• 9.11 Canada - Market size and forecast 2022-2027
• Exhibit 93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.12 Japan - Market size and forecast 2022-2027
• Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
• 9.13 Market opportunity By Geographical Landscape
• Exhibit 101: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 102: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 104: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 105: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 106: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 107: Matrix on vendor position and classification
• 12.3 AbbVie Inc.
• Exhibit 108: AbbVie Inc. - Overview
• Exhibit 109: AbbVie Inc. - Product / Service
• Exhibit 110: AbbVie Inc. - Key offerings
• 12.4 Afaxys Pharma LLC
• Exhibit 111: Afaxys Pharma LLC - Overview
• Exhibit 112: Afaxys Pharma LLC - Product / Service
• Exhibit 113: Afaxys Pharma LLC - Key offerings
• 12.5 Agile Therapeutics Inc.
• Exhibit 114: Agile Therapeutics Inc. - Overview
• Exhibit 115: Agile Therapeutics Inc. - Product / Service
• Exhibit 116: Agile Therapeutics Inc. - Key offerings
• 12.6 Ansell Ltd.
• Exhibit 117: Ansell Ltd. - Overview
• Exhibit 118: Ansell Ltd. - Business segments
• Exhibit 119: Ansell Ltd. - Key news
• Exhibit 120: Ansell Ltd. - Key offerings
• Exhibit 121: Ansell Ltd. - Segment focus
• 12.7 Bayer AG
• Exhibit 122: Bayer AG - Overview
• Exhibit 123: Bayer AG - Business segments
• Exhibit 124: Bayer AG - Key offerings
• Exhibit 125: Bayer AG - Segment focus
• 12.8 CooperSurgical Inc.
• Exhibit 126: CooperSurgical Inc. - Overview
• Exhibit 127: CooperSurgical Inc. - Product / Service
• Exhibit 128: CooperSurgical Inc. - Key offerings
• 12.9 Cupid Ltd.
• Exhibit 129: Cupid Ltd. - Overview
• Exhibit 130: Cupid Ltd. - Product / Service
• Exhibit 131: Cupid Ltd. - Key offerings
• 12.10 Johnson and Johnson
• Exhibit 132: Johnson and Johnson - Overview
• Exhibit 133: Johnson and Johnson - Business segments
• Exhibit 134: Johnson and Johnson - Key news
• Exhibit 135: Johnson and Johnson - Key offerings
• Exhibit 136: Johnson and Johnson - Segment focus
• 12.11 Mayer Laboratories Inc.
• Exhibit 137: Mayer Laboratories Inc. - Overview
• Exhibit 138: Mayer Laboratories Inc. - Product / Service
• Exhibit 139: Mayer Laboratories Inc. - Key offerings
• 12.12 Merck and Co. Inc.
• Exhibit 140: Merck and Co. Inc. - Overview
• Exhibit 141: Merck and Co. Inc. - Business segments
• Exhibit 142: Merck and Co. Inc. - Key news
• Exhibit 143: Merck and Co. Inc. - Key offerings
• Exhibit 144: Merck and Co. Inc. - Segment focus
• 12.13 Mylan NV
• Exhibit 145: Mylan NV - Overview
• Exhibit 146: Mylan NV - Business segments
• Exhibit 147: Mylan NV - Key offerings
• Exhibit 148: Mylan NV - Segment focus
• 12.14 Pfizer Inc.
• Exhibit 149: Pfizer Inc. - Overview
• Exhibit 150: Pfizer Inc. - Product / Service
• Exhibit 151: Pfizer Inc. - Key news
• Exhibit 152: Pfizer Inc. - Key offerings
• 12.15 Reckitt Benckiser Group PLC
• Exhibit 153: Reckitt Benckiser Group PLC - Overview
• Exhibit 154: Reckitt Benckiser Group PLC - Business segments
• Exhibit 155: Reckitt Benckiser Group PLC - Key offerings
• Exhibit 156: Reckitt Benckiser Group PLC - Segment focus
• 12.16 Teva Pharmaceutical Industries Ltd.
• Exhibit 157: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 158: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 159: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 160: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 161: Teva Pharmaceutical Industries Ltd. - Segment focus
• 12.17 Veru Inc.
• Exhibit 162: Veru Inc. - Overview
• Exhibit 163: Veru Inc. - Business segments
• Exhibit 164: Veru Inc. - Key offerings
• Exhibit 165: Veru Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 166: Inclusions checklist
• Exhibit 167: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 168: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 169: Research methodology
• Exhibit 170: Validation techniques employed for market sizing
• Exhibit 171: Information sources
• 13.5 List of abbreviations
• Exhibit 172: List of abbreviations